Bilibili
BILI
14.92
+0.02
+0.13%
Bilibili
US · BILI
#1918 by market cap
Listed 2018
14.92
+0.02
+0.13%
Live - 5344 symbols - heartbeat 97s ago
· 2026-10-08 08:34
Pre-market
14.82
-0.67%
After-hours
14.95
+0.20%
Overnight
14.72
-1.34%
- Market cap
- 6.24B
- P/E (TTM)i
- 27.73
- P/Bi
- 2.68
- EPSi
- 0.41
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on BILI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.28, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.10% YoY
Margins
- Gross margin
- 36.62%
- Operating margin
- 3.71%
- Net margin
- 3.93%
Key ratios & quality
- Enterprise valuei
- -8.12B
- Altman Z-Scorei
- 0.28
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.13B | 6.78B | 12.00B | 19.38B | 21.90B | 22.53B | 26.83B | 30.35B |
| Gross profit | 855.44M | 1.19B | 2.84B | 4.04B | 3.85B | 5.44B | 8.77B | 11.11B |
| Selling & admin expenses | 1.05B | 1.79B | 4.47B | 7.63B | 7.44B | 6.04B | 6.43B | 6.46B |
| Research & development | 537.49M | 894.41M | 1.51B | 2.84B | 4.77B | 4.47B | 3.69B | 3.53B |
| Operating profit | -728.97M | -1.50B | -3.14B | -6.43B | -8.36B | -5.06B | -1.34B | 1.12B |
| Pretax profit | -539.03M | -1.27B | -3.00B | -6.71B | -7.40B | -4.73B | -1.40B | 1.21B |
| Tax | 25.99M | 35.87M | 53.37M | 95.29M | 104.15M | 78.71M | -36.54M | 17.15M |
| Net profit | -565.02M | -1.30B | -3.05B | -6.81B | -7.51B | -4.81B | -1.36B | 1.19B |
| Basic EPS | -3 | -4 | -9 | -18 | -19 | -12 | -3 | 3 |
| Diluted EPS | -2.64 | -3.99 | -8.71 | -17.87 | -18.99 | -11.67 | -3.23 | 2.85 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 7.00B | 7.34B | 7.69B | 8.32B | 7.47B | 7.94B |
| Gross profit | 2.54B | 2.68B | 2.82B | 3.08B | 2.77B | 2.95B |
| Selling & admin expenses | 1.68B | 1.56B | 1.56B | 1.66B | 1.69B | 1.57B |
| Research & development | 841.48M | 866.41M | 904.54M | 921.06M | 921.11M | 1.01B |
| Operating profit | 15.01M | 251.61M | 353.95M | 503.88M | 166.76M | 372.87M |
| Pretax profit | 911.00K | 244.64M | 454.64M | 507.89M | 221.28M | 371.49M |
| Tax | 11.59M | 26.36M | -14.76M | -6.04M | 19.29M | 32.42M |
| Net profit | -10.68M | 218.28M | 469.40M | 513.93M | 202.00M | 339.08M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | -0.02 | 0.51 | 1.05 | 1.14 | 0.48 | 0.78 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 6.55B | 10.32B | 15.74B | 36.45B | 24.45B | 18.73B | 19.76B | 27.55B |
| Cash & ST investments | 5.23B | 8.07B | 12.76B | 30.22B | 19.56B | 15.04B | 16.54B | 24.15B |
| Inventory | 55.03M | 69.91M | 160.01M | 455.77M | 437.45M | 186.50M | 255.19M | 212.48M |
| Total assets | 10.49B | 15.52B | 23.87B | 52.05B | 41.83B | 33.16B | 32.70B | 41.17B |
| Total current liabilities | 3.30B | 4.27B | 7.39B | 12.07B | 17.09B | 18.10B | 14.76B | 20.33B |
| Short-term debt | -- | 95.90M | 250.40M | 1.44B | 6.86B | 7.64B | 1.79B | 5.01B |
| Long-term debt | -- | 3.41B | 8.34B | 17.78B | 8.68B | 646.00K | 3.26B | 4.78B |
| Total liabilities | 3,298,834,000.00 | 7,880,107,000.00 | 16,083,404,000.00 | 30,337,085,000.00 | 26,590,983,000.00 | 18,754,800,000.00 | 18,594,587,000.00 | 25,619,200,000.00 |
| Total equity | 7.19B | 7.64B | 7.78B | 21.72B | 15.24B | 14.40B | 14.10B | 15.55B |
| Retained earnings | -2.84B | -4.15B | -7.18B | -13.97B | -21.48B | -26.31B | -27.66B | -26.47B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 20.58B | 25.57B | 27.00B | 27.55B | 27.69B | 28.17B |
| Cash & ST investments | 17.40B | 22.29B | 23.49B | 24.15B | 24.19B | 24.30B |
| Inventory | 233.74M | 209.11M | -- | 212.48M | -- | -- |
| Total assets | 33.28B | 38.79B | 39.93B | 41.17B | 41.42B | 42.48B |
| Total current liabilities | 15.10B | 16.01B | 16.48B | 20.33B | 20.57B | 21.39B |
| Short-term debt | 2.03B | 1.95B | 1.64B | 5.01B | 4.86B | 4.88B |
| Long-term debt | 3.26B | 8.09B | 8.06B | 4.78B | 4.71B | 4.64B |
| Total liabilities | 18,900,142,000.00 | 24,638,025,000.00 | 25,041,457,000.00 | 25,619,200,000.00 | 25,815,122,000.00 | 26,565,453,000.00 |
| Total equity | 14.38B | 14.16B | 14.89B | 15.55B | 15.61B | 15.91B |
| Retained earnings | -27.67B | -27.45B | -- | -26.47B | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 737.29M | 194.55M | 753.10M | -2.65B | -3.91B | 266.62M | 6.01B | 7.15B |
| Depreciation & amortization | 642.45M | 1.17B | 1.82B | 2.60B | 3.57B | 2.90B | 2.50B | 2.19B |
| Free cash flow | -596.41M | -1.37B | -1.49B | -6.33B | -6.65B | -1.06B | 4.26B | 5.32B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 4.95B | 1.65B | 2.82B | 19.29B | -347.58M | 2.69B | -117.52M | -822.71M |
| Ending cash balance | 3.54B | 4.96B | 4.68B | 7.52B | 10.19B | 7.24B | 10.30B | 12.23B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.30B | 1.99B | -- | -- | -- | -- |
| Depreciation & amortization | 534.40M | 532.03M | -- | -- | -- | -- |
| Free cash flow | 914.61M | 1.60B | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 9.65B | 10.73B | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -13.66 | -18.41 | -41.11 | -46.34 | -40.59 | -32.55 | -9.45 | 8.04 |
| ROA %i | -8.83 | -9.91 | -15.29 | -17.89 | -15.97 | -12.86 | -4.09 | 3.23 |
| ROIC %i | -14.80 | -13.09 | -22.37 | -23.55 | -20.97 | -19.33 | -8.17 | 4.12 |
| 5-year avg ROE %i | -- | -- | -- | -- | -34.21 | -35.80 | -34.01 | -24.18 |
| EBIT margin %i | -17.66 | -18.02 | -24.10 | -33.83 | -32.66 | -20.28 | -4.89 | 4.48 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 15.88 | 17.53 |
| Current ratioi | 1.99 | 2.42 | 2.13 | 3.02 | 1.43 | 1.03 | 1.34 | 1.36 |
| Quick ratioi | 1.72 | 2.15 | 1.92 | 2.79 | 1.32 | 0.97 | 1.26 | 1.30 |
| Debt / assetsi | 0.00 | 22.62 | 36.00 | 36.93 | 37.16 | 23.06 | 15.45 | 23.77 |
| LT debt / equityi | -- | 48.42 | 109.75 | 81.94 | 56.98 | 0.00 | 23.14 | 30.67 |
| Interest coveragei | -- | -26.24 | -26.64 | -42.18 | -28.51 | -27.70 | -14.70 | 9.02 |
| Revenue CAGR (3Y) %i | 215.88 | 134.84 | 69.40 | 67.44 | 47.83 | 23.37 | 11.45 | 11.49 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -4.29 | 1.59 | 5.38 | 8.04 | 9.41 | 10.21 |
| ROA %i | -1.91 | 0.63 | 2.14 | 3.23 | 3.78 | 3.78 |
| ROIC %i | -4.67 | -0.29 | 2.56 | 4.12 | 5.03 | 5.06 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -1.94 | 1.12 | 3.01 | 4.48 | 5.15 | 5.46 |
| FCF / sales %i | 16.86 | 17.90 | -- | 17.53 | -- | -- |
| Current ratioi | 1.36 | 1.60 | 1.64 | 1.36 | 1.35 | 1.32 |
| Quick ratioi | 1.29 | 1.53 | 1.49 | 1.30 | 1.24 | 1.21 |
| Debt / assetsi | 15.92 | 25.89 | 24.27 | 23.77 | 23.09 | 22.40 |
| LT debt / equityi | 22.69 | 57.11 | 54.07 | 30.67 | 30.08 | 29.06 |
| Interest coveragei | -6.05 | 3.10 | 6.88 | 9.02 | 10.08 | 10.76 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:34:38 · For reference only, not investment advice and not tailored to your situation.